PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
Clinical trial NCT05772273 · RECRUITING
Trial details
- NCT number
- NCT05772273
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2026-07-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.